Unlock stock picks and a broker-level newsfeed that powers Wall Street.

20 Countries With Highest Rate Of Breast Cancer In The World

In This Article:

In this article, we will discuss the 20 countries with highest rate of breast cancer in the world. If you want to skip our discussion on the prevalence and incidence rates of the disease, you can go directly to the 5 Countries With Highest Rate Of Breast Cancer In The World.

Globally, breast cancer has become a major public health concern. As per the World Health Organization (WHO), breast cancer has become the most frequently diagnosed type of cancer globally, comprising 11.7% of all cancer cases. In 2020, 2.3 million new cases of breast cancer were reported among women worldwide. Overall, 685,000 people died while battling this disease in the same year. At the end of 2020, there were 7.8 million women across the world who had been diagnosed with breast cancer within the last 5 years. According to breast cancer statistics worldwide, it is anticipated that around 297,790 women in the United States alone will receive a new diagnosis of invasive breast cancer in 2023. There are presently over four million women who have a history of breast cancer in the US, including those currently undergoing treatment and those who have completed their treatment. The United States is also included in the list of the top 10 cancer countries.

According to global cancer statistics, there exists a significant difference in incidence and death rates due to breast cancer among countries. The incidence rates for breast cancer are 88% higher in transitioning countries as compared to transitioned countries due to regular screening, lifestyle as well as hormonal and reproductive risk factors. Scientists and healthcare professionals all over the world are concerned with the growing burden of breast cancer. Researchers have predicted 3 million new cases of breast cancer, along with 1 million deaths attributable to the disease, by the year 2040. Therefore, WHO has launched the WHO Global Breast Cancer Initiative (GBCI) with the aim of reducing the number of deaths caused by the disease by 2.5% annually. The project aims to prevent the deaths of 2.5 million people due to breast cancer between 2020 and 2040. There are three major aspects of this initiative, namely early detection, timely diagnoses, and proper management after the diagnosis.

Due to the increasing incidence of breast cancer and advances in treatment, the market size for breast cancer therapeutics is expected to rise from $26.7 billion in 2022 to $54.7 billion in 2032. Major players in this market include Merck & Co. (NYSE:MRK), Bristol Myers Squibb (NYSE:BMY), and Eli Lilly & Co. (NYSE:LLY). The advances in medical treatment are contributing to a positive outlook for breast cancer survivorship. It is projected that breast cancer survivorship will experience a 24% increase by 2032, reaching a total of 22.5 million individuals. Around 79% of breast cancer survivors globally have surpassed the 5-year mark since their initial diagnosis, while 18% have reached the milestone of 20 years, and 47% have surpassed a decade since their diagnosis. You can also check out the 15 Countries with the Highest Rates of Lung Cancer here.